COVID-19 News Coverage

DOM In the News

Read about how the Department of Medicine is responding to the outbreak of the coronavirus respiratory illness COVID-19. See related COVID-19 publications.

Washington Post.
SF Chronicle.
LA Times.
Washington Post.
LA Times

New coronavirus subvariant Arcturus is now in L.A. Is there reason to worry?

Los Angeles Times |

Peter Chin-Hong spoke to the LA Times about the rise of Covid-19 infections due to the new variant known as Arcturus.

NBC

UCSF Infectious Disease Specialist on New COVID Study

NBC Bay Area |

Peter Chin-Hong appeared on NBC Bay Area News sharing insight about a new study that shows Covid-19 can be transmitted from a mother to her baby. 

 

 

TIME

What to Know About the New XBB.1.16 COVID-19 Variant

TIME |

Monica Gandhi was quoted in Time Magazine discussing a new Covid-19 variant circulating in India, noting there is not a high rise in hospitalizations. 

Washington Post

Covid experts today: Eating out, masking less, even booking cruises

Washington Post |

Monica Gandhi spoke to the Washington Post revealing how the Covid vaccine has influenced her behavior at this stage in the pandemic. 

View all past articles

Recent DOM Covid-19 Publications

Lessons learned from academic medical centers’ response to the COVID-19 pandemic in partnership with the Navajo Nation

Bongiovanni T, Shamasunder S, Brown W III, Rivera Carpenter C, Pantell M, Ghali B, Harrison, JD. Lessons learned from academic medical centers’ response to the COVID-19 pandemic in partnership with the Navajo Nation. PLoS ONE. 2022 17(4): e0265945. View in: PlosOne

Tenofovir-based PrEP for Covid-19: an untapped opportunity?

DeJong C, Spinelli MA, Okochi H, Gandhi M. Tenofovir-based PrEP for Covid-19: an untapped opportunity? AIDS. 2021 Mar 11. [Epub ahead of print]. doi: 10.1097/QAD.0000000000002877. View in: PubMed

Association of human immunodeficiency virus infection with outcomes among adults hospitalized with COVID-19

Durstenfeld MS, Sun K, Ma Y, Rodriguez F, Secemsky EA, Parikh RV, Hsue PY. Association of human immunodeficiency virus infection with outcomes among adults hospitalized with COVID-19. AIDS. 2021 Nov 8. [Epub ahead of print]. doi: 10.1097/QAD.0000000000003129.  View in: PubMed

The evolution of a hospital-based Covid-19 vaccination program for inpatients

Freiser D, Roca M, Chung T, Bhakta T, Winston LG, Ortiz GM. The evolution of a hospital-based Covid-19 vaccination program for inpatients. NEJM Catalyst Innovations in Care Delivery. Vol. 3 No. 2. February 2022. doi: 10.1056/CAT.21.0340. View in: NEJM Catalyst

Incidence of severe COVID-19 illness following vaccination and booster with BNT162b2, mRNA-1273, and Ad26.COV2.S vaccines

Kelly JD, Leonard S, Hoggatt KJ, Boscardin WJ, Lum EN, Moss-Vazquez TA, Andino R, Wong JK, Byers A, Bravata DM, Tien PC, Keyhani S. Incidence of severe COVID-19 illness following vaccination and booster with BNT162b2, mRNA-1273, and Ad26.COV2.S vaccines. JAMA.2022 Oct 11;328(14):1427-1437. doi: 10.1001/jama.2022.17985. View in: PubMed

Routine asymptomatic testing strategies for airline travel during the COVID-19 pandemic: a simulation study

Kiang MV, Chin ET, Huynh BQ, Chapman LAC, Rodríguez-Barraquer I, Greenhouse B, Rutherford GW, Bibbins-Domingo K, Havlir D, Basu S, Lo NC. Routine asymptomatic testing strategies for airline travel during the COVID-19 pandemic: a simulation study. Lancet Infect Dis.2021 Mar 22;S1473-3099(21)00134-1. [Epub ahead of print]. doi: 10.1016/S1473-3099(21)00134-1.View in: PubMed

IL-6 receptor antagonist therapy for patients hospitalized for COVID-19: Who, when, and how?

Matthay MA, Luetkemeyer AF. IL-6 receptor antagonist therapy for patients hospitalized for COVID-19: Who, when, and how? JAMA. 2021 Aug 10;326(6):483-485. doi: 10.1001/jama.2021.11121. View in: PubMed

Early clues regarding the pathogenesis of long-COVID

Peluso MJ, Deeks SG. Early clues regarding the pathogenesis of long-COVID. Trends Immunol.2022 Apr;43(4):268-270. [Epub ahead of print] doi: 10.1016/ j. it.2022.02.008. View in: PubMed

Lack of antinuclear antibodies in convalescent coronavirus disease 2019 patients with persistent symptoms

Peluso MJ, Thomas IJ, Munter SE, Deeks SG, Henrich TJ. Lack of antinuclear antibodies in convalescent coronavirus disease 2019 patients with persistent symptoms. Clin Infect Dis. 2022 Jun 10;74(11):2083-2084. doi: 10.1093/cid/ciab890. View in: PubMed

Long-term SARS-CoV-2-specific immune and inflammatory responses in individuals recovering from COVID-19 with and without post-acute symptoms

Peluso MJ, Deitchman AN, Torres L, Iyer NS, Munter SE, Nixon CC, Donatelli J, Thanh C, Takahashi S, Hakim J, Turcios K, Janson O, Hoh R, Tai V, Hernandez Y, Fehrman EA, Spinelli MA, Gandhi M, Trinh L, Wrin T, Petropoulos CJ, Aweeka FT, Rodriguez-Barraquer I, Kelly JD, Martin JN, Deeks SG, Greenhouse B, Rutishauser RL, Henrich TJ. Long-term SARS-CoV-2-specific immune and inflammatory responses in individuals recovering from COVID-19 with and without post-acute symptoms. Cell Rep. 2021 08 10; 36(6):109518. View in: PubMed

How will Covid-19 transform global health post-pandemic? Defining research and investment opportunities and priorities

Reid M, Abdool-Karim Q, Geng E, Goosby E. How will Covid-19 transform global health post-pandemic? Defining research and investment opportunities and priorities. PLoS Med. 2021 Mar; 18(3):e1003564. eCollection 2021 Mar. doi: 10.1371/journal.pmed.1003564. View in: PubMed

Vaccinated but not protected — living immunocompromised during the pandemic

Ryan L. Vaccinated but not protected — living immunocompromised during the pandemic. JAMA.2021 Jun 22;325(24):2443-2444. doi: 10.1001/jama.2021.9321. View in: PubMed

Differences in post-mRNA vaccination severe acute respiratory syndrome Coronavirus 2 (SARS-CoV-2) immunoglobulin G (IgG) concentrations and surrogate virus neutralization test response by human immunodeficiency virus (HIV) status and type of vaccine: A matched case-control observational study

Spinelli MA, Peluso MJ, Lynch KL, Yun C, Glidden DV, Henrich TJ, Deeks SG, Gandhi M. Differences in post-mRNA vaccination severe acute respiratory syndrome Coronavirus 2 (SARS-CoV-2) immunoglobulin G (IgG) concentrations and surrogate virus neutralization test response by human immunodeficiency virus (HIV) status and type of vaccine: A matched case-control observational study. Clin Infect Dis. 2022 Aug 24;75(1):e916-e919. doi: 10.1093/cid/ciab1009. View in: PubMed

Limited cross-variant immunity from SARS-CoV-2 Omicron without vaccination

Suryawanshi RK, Chen IP, Ma T, Syed AM, Brazer N, Saldhi P, Simoneau CR, Ciling A, Khalid MM, Sreekumar B, Chen PY, Kumar GR, Montano M, Gascon R, Tsou CL, Garcia-Knight MA, Sotomayor-Gonzalez A, Servellita V, Gliwa A, Nguyen J, Silva I, Milbes B, Kojima N, Hess V, Shacreaw M, Lopez L, Brobeck M, Turner F, Soveg FW, George AF, Fang X, Maishan M, Matthay M, Morris MK, Wadford D, Hanson C, Greene WC, Andino R, Spraggon L, Roan NR, Chiu CY, Doudna JA, Ott M. Limited cross-variant immunity from SARS-CoV-2 Omicron without vaccination. Nature. 2022 May 18. [Epub ahead of print]. doi: 10.1038/s41586-022-04865-0. View in: PubMed

Nailing the nuance on COVID-19

Wachter RM. Nailing the nuance on COVID-19. Science. 2022 Jul 15;377(6603):243. [Epub ahead of print]. doi: 10.1126/science.add8599. View in: PubMed

The impact of the COVID-19 pandemic on internet use and use of digital health tools: A secondary analysis of the 2020 health information national trends survey

Zeng B, Rivadeneira NA, Wen A, Sarkar U, Khoong EC. The impact of the COVID-19 pandemic on internet use and use of digital health tools: A secondary analysis of the 2020 health information national trends survey. J Med Internet Res. 2022 Aug 26. [Epub ahead of print]. doi: 10.2196/35828. View in: PubMed

View all UCSF Covid Publications